2006
DOI: 10.1007/bf02705934
|View full text |Cite
|
Sign up to set email alerts
|

Agglomeration behavior of anhydrous L-ornithine-L-aspatate crystals during semi-batch drowning-out crystallization

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
5
0

Year Published

2010
2010
2017
2017

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(5 citation statements)
references
References 13 publications
0
5
0
Order By: Relevance
“…Much work has been performed in order to investigate the spherical agglomeration behavior in the process of crystallization, and several mechanisms toward different spherical crystallization processes have been brought forward. So far, there are two possible methods to obtain the size enlargement of particles during the crystallization step, controlling the minute crystals agglomeration with the goal to obtain spherical agglomerates with controllable properties: (1) spherical agglomeration (SA), which consists of precipitating fine crystals of drug substance then aggregating them using a immiscible liquid (the so-called wetting agent), and (2) quasiemulsion solvent diffusion (QESD), in which a quasiemulsion is formed by droplets of solvent containing the drug and the continuous phase is a liquid in which the drug is immiscible; crystallization occurs inside the droplets because of the counterdiffusion of the solvents through the droplets.…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations
“…Much work has been performed in order to investigate the spherical agglomeration behavior in the process of crystallization, and several mechanisms toward different spherical crystallization processes have been brought forward. So far, there are two possible methods to obtain the size enlargement of particles during the crystallization step, controlling the minute crystals agglomeration with the goal to obtain spherical agglomerates with controllable properties: (1) spherical agglomeration (SA), which consists of precipitating fine crystals of drug substance then aggregating them using a immiscible liquid (the so-called wetting agent), and (2) quasiemulsion solvent diffusion (QESD), in which a quasiemulsion is formed by droplets of solvent containing the drug and the continuous phase is a liquid in which the drug is immiscible; crystallization occurs inside the droplets because of the counterdiffusion of the solvents through the droplets.…”
Section: Resultsmentioning
confidence: 99%
“…Recently, crystals of small size (<10 µm) have attracted more and more attention in biomaterial or pharmaceutical industry ascribing to their high bioavailability and dissolution kinetics. 1 However, due to the poor flowability and compressibility and low bulk density of micronized crystals, their downstream processing may be quite difficult, such as filtration, handling, and storage. Therefore, modification and design of micromeritic properties of pharmaceutical powders, such as flowability, packability, and solubility, are necessary to guarantee stable and reliable powder processing.…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…However, if the solubility is reasonably high at low temperature, product yield would be quite low. In this case, crystallization by drowning-out in which supersaturation is created by adding an antisolvent is effective to improve the overall yield. However, despite the high yield, the drowning-out have a troublesome in the control of the level of supersaturation due to extremely high local supersaturation which is primary cause of the generation of very fine crystals …”
Section: Introductionmentioning
confidence: 99%